MICROCAPS ADARE Trademark
MICROCAPS ADARE is a USPTO trademark filed by ADARE PHARMACEUTICALS s.r.l.. Status: Abandoned.
Trademark Facts
| Mark | MICROCAPS ADARE |
|---|---|
| Serial Number | 79386527 |
| Status | Abandoned |
| Filing Date | 2023-07-21 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals), 040 (Material Treatment), 042 (Software & IT) |
| Owner | ADARE PHARMACEUTICALS s.r.l. |
| Attorney of Record | ROBERT S. BRODER |
| Prosecution Events | 40 |
| Latest Event | DENA on 2025-11-30 |
Goods & Services
Manufacturing services to the order and specification of others of drug dosage forms, drug compositions, drug formulations, drug delivery agents in the nature of tablets, orally disintegrating tablets, minitablets, microtablets, minitablets and microtablets comprising multiparticulates, capsules, lozenges, powders, granules, granulates, sprinkles, sachets, patches, pads, suppositories, creams, gels, ointments, paste, emulsions, suspensions, syrups, elixirs, drops, liquids, skin lotions, vaccines, injectables, aerosols, and sanitary products, all in the pharmaceutical and the veterinary fields; clinical manufacturing of drug compositions for others to support clinical trials; Pharmaceutical, veterinary and sanitary products, namely, drug delivery agents in the form of specialized tablets, orally disintegrating tablets, minitablets, microtablets, minitablets and microtablets comprising multiparticulates, filled capsules, lozenges, powders, granules, granulates, sprinkles, sachets, patches, pads, suppositories, creams, gels, ointments, paste, emulsions, suspensions, syrups, elixirs, drops, liquids, skin lotions, vaccines and injectables used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, bronchoconstriction, thrombocythemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, Alzheimer's, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis; inhalers for medical purposes sold filled with pharmaceutical, veterinary and sanitary preparations for treating asthma, pulmonary hypertension, inflammation of respiratory tract, bronchoconstriction, plasmodium infections and fungal infections; Research and development services in the pharmaceutical and the veterinary fields; product design and development of pharmaceutical preparations including powder and granules for suspension in liquids, semisolid forms, solid forms, capsules, tablets, sachets, sprinkles; research and development in the area of drug delivery systems with customized release, taste masked release, controlled release; technological consultancy services in the field of new product development